Integral Ad Science (NASDAQ:IAS – Get Rating) had its price objective lifted by investment analysts at Barclays from $16.00 to $17.00 in a note issued to investors on Friday, The Fly reports. Barclays‘s price objective suggests a potential upside of 2.41% from the company’s previous close.
Several other brokerages have also recently commented on IAS. TheStreet upgraded Integral Ad Science from a “d+” rating to a “c” rating in a report on Monday, March 20th. Wells Fargo & Company cut their price target on Integral Ad Science from $16.00 to $15.00 and set an “overweight” rating on the stock in a report on Thursday, January 19th. Craig Hallum initiated coverage on Integral Ad Science in a report on Friday, March 31st. They set a “buy” rating and a $18.00 price target on the stock. KeyCorp initiated coverage on Integral Ad Science in a report on Wednesday, April 12th. They set a “sector weight” rating on the stock. Finally, Morgan Stanley increased their price target on Integral Ad Science from $12.00 to $13.00 and gave the stock an “overweight” rating in a report on Wednesday, January 18th. Two analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Integral Ad Science has an average rating of “Moderate Buy” and an average price target of $16.00.
Integral Ad Science Stock Up 4.3 %
Shares of NASDAQ IAS opened at $16.60 on Friday. The company has a current ratio of 3.26, a quick ratio of 3.26 and a debt-to-equity ratio of 0.28. The company has a market cap of $2.56 billion, a price-to-earnings ratio of 184.46 and a beta of 1.72. Integral Ad Science has a 12 month low of $6.63 and a 12 month high of $17.68. The stock has a 50-day moving average price of $14.02 and a two-hundred day moving average price of $10.99.
Integral Ad Science (NASDAQ:IAS – Get Rating) last released its quarterly earnings data on Thursday, March 2nd. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.06. Integral Ad Science had a return on equity of 2.20% and a net margin of 4.08%. The company had revenue of $117.44 million during the quarter, compared to the consensus estimate of $111.74 million. As a group, analysts forecast that Integral Ad Science will post 0.1 earnings per share for the current fiscal year.
Insider Transactions at Integral Ad Science
In other news, insider Tom Sharma sold 9,204 shares of the stock in a transaction on Thursday, April 27th. The stock was sold at an average price of $16.00, for a total transaction of $147,264.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Integral Ad Science news, insider Tom Sharma sold 9,204 shares of the firm’s stock in a transaction dated Thursday, April 27th. The stock was sold at an average price of $16.00, for a total value of $147,264.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, COO Oleg Bershadsky sold 9,150 shares of the firm’s stock in a transaction dated Monday, April 3rd. The stock was sold at an average price of $14.34, for a total value of $131,211.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 139,667 shares of company stock worth $1,928,288. 2.00% of the stock is owned by company insiders.
Institutional Trading of Integral Ad Science
A number of large investors have recently modified their holdings of IAS. JPMorgan Chase & Co. boosted its position in shares of Integral Ad Science by 286.0% during the 1st quarter. JPMorgan Chase & Co. now owns 119,294 shares of the company’s stock valued at $1,646,000 after acquiring an additional 88,390 shares during the last quarter. Bank of New York Mellon Corp lifted its position in Integral Ad Science by 74.3% in the 1st quarter. Bank of New York Mellon Corp now owns 87,728 shares of the company’s stock worth $1,210,000 after buying an additional 37,393 shares during the last quarter. Bank of Montreal Can lifted its position in Integral Ad Science by 3.5% in the 1st quarter. Bank of Montreal Can now owns 149,859 shares of the company’s stock worth $2,155,000 after buying an additional 5,018 shares during the last quarter. MetLife Investment Management LLC lifted its position in Integral Ad Science by 185.3% in the 1st quarter. MetLife Investment Management LLC now owns 19,760 shares of the company’s stock worth $273,000 after buying an additional 12,835 shares during the last quarter. Finally, Rhumbline Advisers lifted its position in Integral Ad Science by 112.4% in the 1st quarter. Rhumbline Advisers now owns 33,014 shares of the company’s stock worth $456,000 after buying an additional 17,470 shares during the last quarter. Institutional investors own 96.83% of the company’s stock.
Integral Ad Science Company Profile
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, Germany, Italy, Spain, Sweden, Singapore, Australia, France, Japan, Canada, India, and Brazil. The company provides IAS Signal, a cloud-based technology platform that offers actionable insights; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Further Reading
Receive News & Ratings for Integral Ad Science Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Integral Ad Science and related companies with MarketBeat.com’s FREE daily email newsletter.
#Barclays #Increases #Integral #Science #NASDAQIAS #Price #Target